232 related articles for article (PubMed ID: 10707560)
1. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
Sugiyama Y; Murase K; Ikeda H
Nihon Rinsho; 2000 Feb; 58(2):370-5. PubMed ID: 10707560
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
Sugiyama Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():416-21. PubMed ID: 12387027
[No Abstract] [Full Text] [Related]
3. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi P; Xu M; Spiegelman BM
J Clin Invest; 1997 Oct; 100(7):1863-9. PubMed ID: 9312188
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and additional vascular effects of thiazolidinediones.
Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological effects of a thiazolidinedione derivative, pioglitazone].
Ikeda H; Sugiyama Y
Nihon Rinsho; 2001 Nov; 59(11):2191-4. PubMed ID: 11712406
[TBL] [Abstract][Full Text] [Related]
7. [Pioglitazone].
Kobayashi M; Iwata M; Hiratani K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
[No Abstract] [Full Text] [Related]
8. Novel insulin sensitizers: pharmacogenomic aspects.
Otto C; Lehrke M; Göke B
Pharmacogenomics; 2002 Jan; 3(1):99-116. PubMed ID: 11966407
[TBL] [Abstract][Full Text] [Related]
9. [Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
Satoh J
Nihon Rinsho; 2003 Jul; 61(7):1224-9. PubMed ID: 12877089
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone: mechanism of action.
Smith U
Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes.
Dello Russo C; Gavrilyuk V; Weinberg G; Almeida A; Bolanos JP; Palmer J; Pelligrino D; Galea E; Feinstein DL
J Biol Chem; 2003 Feb; 278(8):5828-36. PubMed ID: 12486128
[TBL] [Abstract][Full Text] [Related]
12. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
Wang M; Tafuri S
J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of a thiazolidinedione compound as a new antidiabetic drug].
Toyota T
Nihon Rinsho; 2001 Nov; 59(11):2211-8. PubMed ID: 11712410
[TBL] [Abstract][Full Text] [Related]
14. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.
Sakamoto J; Kimura H; Moriyama S; Odaka H; Momose Y; Sugiyama Y; Sawada H
Biochem Biophys Res Commun; 2000 Nov; 278(3):704-11. PubMed ID: 11095972
[TBL] [Abstract][Full Text] [Related]
15. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
Fukui Y; Masui S; Osada S; Umesono K; Motojima K
Diabetes; 2000 May; 49(5):759-67. PubMed ID: 10905484
[TBL] [Abstract][Full Text] [Related]
16. [Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)].
Dubois M; Vantyghem MC; Schoonjans K; Pattou F
Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):511-23. PubMed ID: 12527853
[TBL] [Abstract][Full Text] [Related]
17. A PPAR agonist improves TNF-alpha-induced insulin resistance of adipose tissue in mice.
Shibasaki M; Takahashi K; Itou T; Bujo H; Saito Y
Biochem Biophys Res Commun; 2003 Sep; 309(2):419-24. PubMed ID: 12951066
[TBL] [Abstract][Full Text] [Related]
18. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.
Vázquez M; Silvestre JS; Prous JR
Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):515-23. PubMed ID: 12500431
[TBL] [Abstract][Full Text] [Related]
19. [Rosiglitazone (BRL-49653)].
Oka Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
[No Abstract] [Full Text] [Related]
20. [Insulin resistance-reducing effect of a new thiazolidinedione derivative, pioglitazone].
Ikeda H; Sugiyama Y
Nihon Yakurigaku Zasshi; 2001 May; 117(5):335-42. PubMed ID: 11411343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
